Patents by Inventor Frank Van Bel

Frank Van Bel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating perinatal asphyxia in a human or animal neonate
    Patent number: 7087633
    Abstract: A method for treating perinatal asphyxia is disclosed comprising administering 2-iminobiotin or a salt or ester thereof.
    Type: Grant
    Filed: July 13, 2004
    Date of Patent: August 8, 2006
    Assignee: Universitair Medisch Centrum
    Inventors: Cacha Marie Pétronelle Cathérine Dorotheé Peeters, Floris Groenendaal, Frank Van Bel
  • Method for treating perinatal asphyxia in a human or animal neonate
    Patent number: 6894069
    Abstract: A selective inhibitor of neuronal nitric oxide synthase (nNOS) and of inducible nitric oxide synthase (iNOS), which does not substantially inhibit endothelial nitric oxide synthase (eNOS), can be effectively used for the treatment, in human or other mammalian neonates, of the effects of complications during childbirth. Such effects include perinatal asphyxia and hypoxia-ischemia. A very useful example of such a selective inhibitor is 2-iminobiotin.
    Type: Grant
    Filed: March 30, 2001
    Date of Patent: May 17, 2005
    Assignee: Universitair Medisch Centrum
    Inventors: Cacha Marie Pétronelle Cathérine Dorotheé Peetres, Floris Groenendaal, Frank Van Bel
  • Method for preventing and/or treating perinatal asphyxia in a human or animal neonate
    Publication number: 20050009915
    Abstract: A selective inhibitor of neuronal nitric oxide synthase (nNOS) and of inducible nitric oxide synthase (iNOS), which does not substantially inhibit endothelial nitric oxide synthase (eNOS), can be effectively used for the treatment, in human or other mammalian neonates, of the effects of complications during childbirth. Such effects include perinatal asphyxia and hypoxia-ischemia. A very useful example of such a selective inhibitor is 2-iminobiotin.
    Type: Application
    Filed: July 13, 2004
    Publication date: January 13, 2005
    Inventors: Cacha Marie Dorothee Peeters, Floris Groenendaal, Frank Van Bel
  • Composition for the prevention and/or treatment in newborn babies of the effects of complications during childbirth
    Publication number: 20040002530
    Abstract: A selective inhibitor of neuronal nitric oxide synthase (nNOS) and of inducible nitric oxide synthase (iNOS), which does not substantially inhibit endothelial nitric oxide synthase (eNOS), can be effectively used for the treatment, in human or other mammalian neonates, of the effects of complications during childbirth. Such effects include perinatal asphyxia and hypoxia-ischemia. A very useful example of such a selective inhibitor is 2-iminobiotin.
    Type: Application
    Filed: July 10, 2003
    Publication date: January 1, 2004
    Inventors: Cacha Marie Petronelle Catherine Dorothee Peeters, Floris Groenendaal, Frank Van Bel